Expert Ratings
Easily search Stocks, Mutual Funds, Articles and Videos
Track the companies of Group.
| Sales Growth | Profit Growth | Expense Growth | Stock Price CAGR |
|---|---|---|---|
Presentation & Earning Calls |
Annual Reports |
Credit Rating |
|---|---|---|
|
|
|
|
Sai Life Sciences Limited was originally incorporated as ‘Sai Dru Syn Laboratories Limited’ at Hyderabad, Telangana (erstwhile Andhra Pradesh) as a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated January 25, 1999, issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. The company received the certificate of commencement of business from Registrar of Companies, Andhra Pradesh at Hyderabad on February 17, 1999. Subsequently, the name of the company was changed from ‘Sai Dru Syn Laboratories Limited’ to ‘Sai Life Sciences Limited’ pursuant to a Shareholders’ resolution in an extraordinary general meeting held on December 11, 2003 and a fresh certificate of incorporation dated December 16, 2003 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Thereafter, the name of the Company was changed from ‘Sai Life Sciences Limited’ to ‘Sai Advantium Pharma Limited’ pursuant to a Shareholders’ resolution in an extraordinary general meeting held on August 16, 2006 and a fresh certificate of incorporation dated August 30, 2006 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad. Subsequently, the name of the company was changed from ‘Sai Advantium Pharma Limited’ to its present name, ‘Sai Life Sciences Limited’ pursuant to a Shareholders’ resolution in an extraordinary general meeting held on April 20, 2012 and a fresh certificate of incorporation dated May 28, 2012 consequent to change of name was issued by the Registrar of Companies, Andhra Pradesh at Hyderabad.
The company is an innovator-focused, contract research, development, and manufacturing organization (CRDMO). It provides end-to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to global pharmaceutical innovator companies and biotechnology firms. It possesses both (a) discovery / contract research (CRO) and (b) chemistry, manufacturing, and control (CMC) / contract development and manufacturing organization (CDMO) capabilities. It is also one of the few CRDMOs to have a differentiated delivery model of having research laboratories for discovery and development located near overseas innovation hubs at Watertown (Greater Boston, MA), United States (US) and Manchester, United Kingdom (UK), complemented by large-scale research laboratories and manufacturing facilities in cost competitive locations in India.
Its CRO services include integrated discovery (Discovery) capabilities across biology, chemistry, and drug metabolism and pharmacokinetics (DMPK). Its CDMO services include comprehensive capabilities that support its customers in the development and scaling up production of active pharmaceutical ingredients (APIs) (i.e., the active ingredients used in medications) and intermediates (i.e., chemical compounds used for the manufacture of APIs) for clinical phase and commercial phase supplies.
It provides its services through its globally accredited manufacturing and R&D facilities with quality systems that are supported by a qualified pool of scientists, engineers, and other scientific staff. Furthermore, it is led by an experienced management team, with its senior management having years of experience in the global CRDMO industry. Its management team is guided by its Chairman and Whole time Director, Kanumuri Ranga Raju and Managing Director and Chief Executive Officer, Krishnam Raju Kanumuri.
Business area of the company
The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms. It possesses both (a) discovery / contract research and (b) chemistry, manufacturing, and control / contract development and manufacturing organization capabilities.
Awards, accreditations and recognitions
History and milestones
Comment